CD86 and neoplasm: We then examined the changes in M2-like TAM markers (CD163, CD206, CD209, IL-10 and Arginase 1) and M1-like TAM markers (CD80, CD86, IL-12, and TNFα) induced by CM from ILT4-downregulated tumor cells.